|
1
|
Huo J, Bian XH, Huang Y, Miao ZC and Song
LH: Inhibitory effect and mechanism of metformin on human ovarian
cancer cells SKOV-3 and A2780. Eur Rev Med Pharmacol Sci.
21:484–489. 2017.PubMed/NCBI
|
|
2
|
Li R, Dong T, Hu C, Lu J, Dai J and Liu P:
Salinomycin repressed the epithelial-mesenchymal transition of
epithelial ovarian cancer cells via downregulating Wnt/b-catenin
pathway. Onco Targets Ther. 10:1317–1325. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perroud HA, Scharovsky OG, Rozados VR and
Alasino CM: Clinical response in patients with ovarian cancer
treated with metronomic chemotherapy. Ecancermedicalscience.
11:7232017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee HH, Bellat V and Law B: Chemotherapy
induces adaptive drug resistance and metastatic potentials via
phenotypic CXCR4-expressing cell state transition in ovarian
cancer. PLoS One. 12:e01710442017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen Y, Ng F and Tang BL: Rab23 activities
and human cancer-emerging connections and mechanisms. Tumour Biol.
37:12959–12967. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jian Q, Miao Y, Tang L, Huang M, Yang Y,
Ba W, Liu Y, Chi S and Li C: Rab23 promotes squamous cell carcinoma
cell migration and invasion via integrin b1/Rac1 pathway.
Oncotarget. 7:5342–5352. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang M, Dong Q and Wang Y: Rab23 is
overexpressed in human astrocytoma and promotes cell migration and
invasion through regulation of Rac1. Tumour Biol. 37:11049–11055.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Denning KM, Smyth PC, Cahill SF, Finn SP,
Conlon E, Li J, Flavin RJ, Aherne ST, Guenther SM, Ferlinz A, et
al: A molecular expression signature distinguishing follicular
lesions in thyroid carcinoma using preamplification RT-PCR in
archival samples. Mod Pathol. 20:1095–1102. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Zeng C, Bao N, Zhao J, Hu Y, Li C
and Chi S: Effect of Rab23 on the proliferation and apoptosis in
breast cancer. Oncol Rep. 34:1835–1844. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai ZZ, Xu LB, Cai JL, Wang JS, Zhou B and
Hu H: Inactivation of Rab23 inhibits the invasion and motility of
pancreatic duct adenocarcinoma. Genet Mol Res. 14:2707–2715. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chang J, Xu W, Liu G, Du X and Li X:
Downregulation of Rab23 in prostate cancer inhibits tumor growth in
vitro and in vivo. Oncol Res. 25:241–248. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishihashi K, Kawashima K, Nomura T,
Urakami-Takebayashi Y, Miyazaki M, Takano M and Nagai J: Cobalt
chloride induces expression and function of breast cancer
resistance protein (BCRP/ABCG2) in human renal proximal tubular
epithelial cell line HK-2. Biol Pharm Bull. 40:82–87. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Yunyun Z, Wang L, Chen X and Zhu
Z: ABCG2 confers promotion in gastric cancer through modulating
downstream CRKL in vitro combining with biostatistics mining.
Oncotarget. 8:5256–5267. 2017.PubMed/NCBI
|
|
14
|
Kuo WY, Hwu L, Wu CY, Lee JS, Chang CW and
Liu RS: STAT3/NF-kB-regulated lentiviral TK/GCV suicide gene
therapy for cisplatin-resistant triple-negative breast cancer.
Theranostics. 7:647–663. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Maeda O, Matsuoka A, Miyahara R, Funasaka
K, Hirooka Y, Fukaya M, Nagino M, Kodera Y, Goto H and Ando Y:
Modified docetaxel, cisplatin and capecitabine for stage IV gastric
cancer in Japanese patients: A feasibility study. World J
Gastroenterol. 23:1090–1097. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie XQ, Zhao QH, Wang H and Gu KS:
Dysregulation of mRNA profile in cisplatin-resistant gastric cancer
cell line SGC7901. World J Gastroenterol. 23:1189–1202. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Du Z, Zhou F, Jia Z, Zheng B, Han S, Cheng
J, Zhu G and Huang P: The hedgehog/Gli-1 signaling pathways is
involved in the inhibitory effect of resveratrol on human
colorectal cancer HCT116 cells. Iran J Basic Med Sci. 19:1171–1176.
2016.PubMed/NCBI
|
|
18
|
Merchant JL and Ding L: Hedgehog signaling
links chronic inflammation to gastric cancer precursor lesions.
Cell Mol Gastroenterol Hepatol. 3:201–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee HJ, Wu Q, Li H, Bae GU, Kim AK and Ryu
JH: A sesquiterpene lactone from Siegesbeckia glabrescens
suppresses Hedgehog/Gli-mediated transcription in pancreatic cancer
cells. Oncol Lett. 12:2912–2917. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khatra H, Kundu J, Khan PP, Duttagupta I,
Pattanayak S and Sinha S: Piperazic acid derivatives inhibit Gli1
in Hedgehog signaling pathway. Bioorg Med Chem Lett. 26:4423–4426.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chi S, Xie G, Liu H, Chen K, Zhang X, Li C
and Xie J: Rab23 negatively regulates Gli1 transcriptional factor
in a Su(Fu)-dependent manner. Cell Signal. 24:1222–1228. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fuller K, O'Connell JT, Gordon J, Mauti O
and Eggenschwiler J: Rab23 regulates Nodal signaling in vertebrate
left-right patterning independently of the Hedgehog pathway. Dev
Biol. 391:182–195. 2014. View Article : Google Scholar : PubMed/NCBI
|
